Artificial intelligence predicts the outcomes of cancer treatments. The melding of visual information (microscopic and…
Browsing: Immunotherapy
Immunotherapy is a form of medical treatment that enhances the body’s natural immune system to fight diseases, most notably cancer. It represents a significant shift from traditional treatments like chemotherapy and radiation, as it often leads to fewer side effects and can be more precisely targeted. There are several types of immunotherapies, including checkpoint inhibitors that help the immune system recognize and attack cancer cells, cancer vaccines that trigger the immune system to act against certain cancer-related antigens, and adoptive cell therapies where immune cells are taken from the patient, engineered to be more effective, and reintroduced into the body. This treatment is also being explored for its potential against autoimmune diseases, allergies, and infectious diseases like HIV. The success of immunotherapy has transformed oncology, offering hope for durable responses and even remissions in situations where other treatments have failed.
Scientists have discovered significant discrepancies in PD-1 between humans and rodents, indicating that common lab…
New insights into the impact of checkpoint inhibitors on the immune system may enhance cancer…
gemA groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells.…
The method employs ultrathin membranes to capture small packets of cellular material known as extracellular…
Researchers discovered that ovarian tumors hinder T cells’ energy supply by trapping a key protein,…
Immunotherapy has set a new standard in treating Hodgkin lymphoma, showing a 92% survival rate…
Researchers identified five factors that predict response to immunotherapy, advancing personalized cancer treatment. This could…
A study on mice demonstrates that engineered immune cell therapy safeguards damaged neurons. Severe spinal…
A study revealed that tumors block immune responses by using prostaglandin E2, providing new insights…
The use of poly-ICLC in combination with a dendritic cell-based immunotherapy vaccine shows promise as…
Researchers from the University of Houston identified CD8-fit T cells with high motility and serial…
A new immunotherapy developed at UCL using engineered immune cells has shown promising preclinical results…
Researchers at Trinity College Dublin have achieved a significant breakthrough that could lead to the…
The final work of a late scientist from the University of Virginia School of Medicine…
FOXO1 is required for T cell memory and is linked to longer-lasting clinical outcomes in…
A new study conducted by the University of British Columbia reveals a safe path to…
By leveraging mutations from cancerous cells, researchers have engineered T cells that are over 100…